530207 — Brawn Biotech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹55.51m
- IN₹41.13m
- IN₹164.95m
- 10
- 42
- 37
- 16
Annual balance sheet for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 15.7 | 15.2 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 53.3 | 39 |
| Total Inventory | ||
| Total Other Current Assets | ||
| Total Current Assets | 134 | 131 |
| Net Property, Plant And Equipment | 3.72 | 3.33 |
| Long Term Notes Receivable | ||
| Other Long Term Assets | ||
| Total Assets | 145 | 146 |
| Accounts Payable | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 80.5 | 65.1 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 82.2 | 95.2 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 63.1 | 50.7 |
| Total Liabilities & Shareholders' Equity | 145 | 146 |
| Total Common Shares Outstanding |